menu
Main Data: 31/12 Year 2018 | |
Consolidated income statement (international practice in accordance with IAS/IFRS) | Millions/Euro |
– total revenues | 1,500.37 |
– industrial gross profit | 572.04 |
– total operating cost | 361.98 |
– operating profit | 210.06 |
– net financial expense | o.54 |
– profit attributable to equity holders of the parent | 104.03 |
Consolidated balance sheet | Millions/Euro |
– working capital | 99.08 |
– non-current assets | 623.66 |
– provision for severance indemnities and other provisions | -117.23 |
– net debt | -184.58 |
– equity pertaining to the group and minority interests | 420.93 |
Other information | Millions/Euro |
– depreciation and amortization and impairement | 44.08 |
– R & D costs | 55.31 |
Euro | |
Dividend per share | 1.70 |
No. | |
Employees | 5,456 |
Euro | |
Share capital | 20,415,200 |
Net Sales By Sector: Year 2018 | ||
Millions/Euro | ||
tea, food & other | 686.17 | 45.7% |
pharmaceutical | 631.27 | 42.1% |
tobacco packaging | 182.93 | 12.2% |
Total | 1,500.37 | 100.0% |
Net Sales by Country: Year 2018 | ||
Millions/Euro | ||
E.U. (excluding Italy) | 450.01 | 30.0% |
Other European countries | 114.97 | 7.7% |
North America | 241.13 | 16.1% |
Asia & Middle East | 375.66 | 25.0% |
Other countries | 150.95 | 10.0% |
Total exports | 1,332.72 | 88.8% |
Italy | 167.65 | 11.2% |
Total | 1,500.37 | 100.0% |
Main Data: 30/06 Year 2018 | |
Consolidated income statement (international practice in accordance with IAS/IFRS) | Millions/Euro |
– total revenue | 730.1 |
– industrial gross profit | 264.5 |
– total operating cost | 195.3 |
– operating profit | 69.2 |
– net financial income | 5.8 |
– profit attributable to equity holders of the parent | 43.9 |
Consolidated balance sheet | Millions/Euro |
– working capital | 84.3 |
– non-current assets | 643.3 |
– provision for severance indemnities and other provisions | -140.2 |
– net debt | -230.5 |
– equity pertaining to the group and minority interests | 356.9 |
Other information | Millions/Euro |
– depreciation and amortization | 22.7 |
– R & D costs | 29.0 |
No. | |
Employees | 5,729 |
Euro | |
Share capital | 20,415,200 |